Publications by authors named "Daniel Cua"

100Publications

IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice.

J Immunol 2020 Jul 17;205(2):346-358. Epub 2020 Jun 17.

Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.2000280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374065PMC
July 2020

The IL-17 Family of Cytokines in Health and Disease.

Immunity 2019 04;50(4):892-906

Division of Rheumatology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10747613193013
Publisher Site
http://dx.doi.org/10.1016/j.immuni.2019.03.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474359PMC
April 2019

IL-23 promotes the development of castration-resistant prostate cancer.

Immunol Cell Biol 2018 10 8;96(9):883-885. Epub 2018 Sep 8.

Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/imcb.12195
Publisher Site
http://dx.doi.org/10.1111/imcb.12195DOI Listing
October 2018

Experimental Lung Metastases in Mice Are More Effectively Inhibited by Blockade of IL23R than IL23.

Cancer Immunol Res 2018 08 19;6(8):978-987. Epub 2018 Jun 19.

Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-18-0011DOI Listing
August 2018

IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema.

Am J Respir Cell Mol Biol 2016 11;55(5):697-707

1 Department of Hematology, Oncology, Allergy and Respiratory Medicine, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1165/rcmb.2016-0015OCDOI Listing
November 2016

IL-17A-producing CD30(+) Vδ1 T cells drive inflammation-induced cancer progression.

Cancer Sci 2016 Sep 1;107(9):1206-14. Epub 2016 Sep 1.

Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/cas.13005
Publisher Site
http://dx.doi.org/10.1111/cas.13005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021032PMC
September 2016

Cutting Edge: CLEC5A Mediates Macrophage Function and Chronic Obstructive Pulmonary Disease Pathologies.

J Immunol 2016 Apr 29;196(8):3227-31. Epub 2016 Feb 29.

Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1500978DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821706PMC
April 2016

Melatonin Lulling Th17 Cells to Sleep.

Cell 2015 Sep;162(6):1212-4

IMR Pathway Biology, Merck Research Laboratory, 901 California Avenue, Palo Alto, CA 94304, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2015.08.054DOI Listing
September 2015

IL-26 AMPs up the T(H)17 arsenal.

Nat Immunol 2015 Sep;16(9):897-8

Merck Research Laboratory Palo Alto, Pathways of Inflammation, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni.3256DOI Listing
September 2015

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.

Nat Med 2015 Jul 29;21(7):719-29. Epub 2015 Jun 29.

Merck Research Laboratories, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.3895DOI Listing
July 2015

Spondyloarthropathy: interleukin 23 and disease modification.

Lancet 2015 May;385(9982):2017-8

Merck Research Laboratories, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)60970-9DOI Listing
May 2015

A Highly Focused Antigen Receptor Repertoire Characterizes γδ T Cells That are Poised to Make IL-17 Rapidly in Naive Animals.

Front Immunol 2015 23;6:118. Epub 2015 Mar 23.

Department of Microbiology and Immunology, Stanford University School of Medicine , Stanford, CA , USA ; Program in Immunology, Stanford University School of Medicine , Stanford, CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2015.00118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370043PMC
April 2015

IL-23 p19 knockout mice exhibit minimal defects in responses to primary and secondary infection with Francisella tularensis LVS.

PLoS One 2014 8;9(10):e109898. Epub 2014 Oct 8.

Laboratory of Mycobacterial Diseases and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0109898PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190412PMC
October 2015

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.

Nat Rev Immunol 2014 Sep;14(9):585-600

Merck Research Laboratories, Palo Alto, 901 California Avenue, Palo Alto, California 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nri3707DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281037PMC
September 2014

IL-23 promotes TCR-mediated negative selection of thymocytes through the upregulation of IL-23 receptor and RORγt.

Nat Commun 2014 Jul 8;5:4259. Epub 2014 Jul 8.

1] Division of Clinical Immunology & Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA [2] Birmingham VA Medical Center, Birmingham, Alabama 35233, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms5259DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136447PMC
July 2014

The emerging landscape of RORγt biology.

Immunity 2014 Apr;40(4):451-2

Merck Research Laboratories, Palo Alto, CA 94304, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2014.04.005DOI Listing
April 2014

The critical role of interleukin-23 in spondyloarthropathy.

Mol Immunol 2014 Jan 1;57(1):38-43. Epub 2013 Aug 1.

University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, OX3 7HE, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2013.06.010DOI Listing
January 2014

Interleukin-23: a promising therapeutic target in seronegative spondyloarthropathy.

Curr Opin Pharmacol 2013 Jun 26;13(3):445-8. Epub 2013 Mar 26.

University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coph.2013.03.002DOI Listing
June 2013

Th17 cell development: from the cradle to the grave.

Immunol Rev 2013 Mar;252(1):78-88

Pathway Biology, Merck Research Laboratories, Palo Alto, CA 94304-1104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imr.12036DOI Listing
March 2013

Therapeutic potential of targeting IL-17.

Nat Immunol 2012 Nov;13(11):1022-5

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni.2450DOI Listing
November 2012

IFN-γ protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils.

J Neuroinflammation 2012 May 29;9:104. Epub 2012 May 29.

Department of Neurosciences NC30, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1742-2094-9-104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419086PMC
May 2012

Orphan cytokine reveals IL-17 family secret.

Immunity 2011 Oct;35(4):498-500

Merck Research Laboratories, 901 California Avenue, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2011.10.008DOI Listing
October 2011

Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

J Clin Invest 2011 Nov 17;121(11):4446-61. Epub 2011 Oct 17.

Discovery Research, Merck Research Laboratories, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI57682DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204838PMC
November 2011

Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production.

Eur J Immunol 2011 Oct 31;41(10):2828-39. Epub 2011 Aug 31.

Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201141291DOI Listing
October 2011

Autoimmunity's collateral damage: Gut microbiota strikes 'back'.

Nat Med 2011 Sep 7;17(9):1055-6. Epub 2011 Sep 7.

Merck Research Laboratories, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0911-1055DOI Listing
September 2011

Fate mapping of IL-17-producing T cells in inflammatory responses.

Nat Immunol 2011 Mar 30;12(3):255-63. Epub 2011 Jan 30.

Division of Molecular Immunology, Medical Research Council National Institute for Medical Research, Mill Hill, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni.1993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040235PMC
March 2011

IL-17 regulates adipogenesis, glucose homeostasis, and obesity.

J Immunol 2010 Dec 29;185(11):6947-59. Epub 2010 Oct 29.

Laboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305-5324, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1001269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001125PMC
December 2010

Innate IL-17-producing cells: the sentinels of the immune system.

Nat Rev Immunol 2010 Jul 18;10(7):479-89. Epub 2010 Jun 18.

Merck Research Laboratories, DNAX Discovery Research, 901 California Avenue, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nri2800DOI Listing
July 2010

Natural occurring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses.

J Immunol 2009 Dec 4;183(11):7523-30. Epub 2009 Nov 4.

Laboratory for Signal Network, Research Center for Allergy and Immunology, RIKEN Yokohama Institute, Tsurumi, Yokohama, Kanagawa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0803828DOI Listing
December 2009

Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.

Immunity 2009 Aug 13;31(2):321-30. Epub 2009 Aug 13.

Division of Molecular Immunology, MRC National Institute for Medical Research, Mill Hill, London NW7 1AA, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S107476130900320
Publisher Site
http://dx.doi.org/10.1016/j.immuni.2009.06.020DOI Listing
August 2009

Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury.

Nat Med 2009 Aug 2;15(8):946-50. Epub 2009 Aug 2.

Department of Microbiology and Immunology, School of Medicine, Keio University, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.1999DOI Listing
August 2009

Role of IL-23 in mobilization of immunoregulatory nitric oxide- or superoxide-producing Gr-1+ cells from bone marrow.

Free Radic Biol Med 2009 Aug 3;47(4):357-63. Epub 2009 May 3.

Department of Neurology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2009.04.029DOI Listing
August 2009

Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control.

J Virol 2009 Jun 1;83(12):5978-86. Epub 2009 Apr 1.

Department of Neuroscience NC30, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.00315-09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687402PMC
June 2009

Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.

Rheumatology (Oxford) 2009 Apr 22;48(4):347-54. Epub 2009 Jan 22.

Department of Ophthalmology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ken489DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722800PMC
April 2009

Reconciling id, ego, and superego within interleukin-23.

Immunol Rev 2008 Dec;226:103-11

Schering-Plough Biopharma, DNAX Discovery Research, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-065X.2008.00715.xDOI Listing
December 2008

Alternative lifestyles of T cells.

Nat Immunol 2008 Dec;9(12):1323-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni1208-1323DOI Listing
December 2008

Cytokines that regulate autoimmunity.

Curr Opin Immunol 2008 Dec 17;20(6):663-8. Epub 2008 Oct 17.

Discovery Research, Schering-Plough Biopharma (formerly DNAX Research Institute), 901 California Avenue, Palo Alto CA 94304, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2008.09.003DOI Listing
December 2008

Th17 cell differentiation: the long and winding road.

Immunity 2008 Apr;28(4):445-53

Schering-Plough Biopharma, 901 California Avenue, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2008.03.001DOI Listing
April 2008

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.

J Exp Med 2008 Apr 7;205(4):799-810. Epub 2008 Apr 7.

Laboratory of Immunology, National Eye Institute (NEI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20071258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292220PMC
April 2008

SnapShot: Cytokines IV.

Cell 2008 Mar;132(6):1062.e1-2

Schering-Plough Biopharma (Formerly DNAX Research), Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2008.02.024DOI Listing
March 2008

SnapShot: cytokines III.

Cell 2008 Mar;132(5):900

Schering-Plough Biopharma, Palo Alto, CA 94304, USA

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009286740800271
Publisher Site
http://dx.doi.org/10.1016/j.cell.2008.02.023DOI Listing
March 2008

The link between IL-23 and Th17 cell-mediated immune pathologies.

Semin Immunol 2007 Dec 3;19(6):372-6. Epub 2007 Dec 3.

Schering-Plough Biopharma (Formerly DNAX Research), 901 California Avenue, Palo Alto, CA 94304, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.smim.2007.10.012DOI Listing
December 2007

SnapShot: cytokines II.

Cell 2008 Feb;132(3):500

Schering-Plough Biopharma, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2008.01.002DOI Listing
February 2008

IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17.

J Immunol 2008 Feb;180(4):2486-95

Department of Pathology, School of Medicine, Tufts University, 150 Harrison Avenue, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.180.4.2486DOI Listing
February 2008

SnapShot: Cytokines I.

Cell 2008 Jan;132(2):324, 324.e1

Schering-Plough Biopharma, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009286740800048
Publisher Site
http://dx.doi.org/10.1016/j.cell.2008.01.001DOI Listing
January 2008

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Nat Immunol 2007 Dec 11;8(12):1390-7. Epub 2007 Nov 11.

Schering-Plough Biopharma, Palo Alto, California 94304, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ni1539
Publisher Site
http://dx.doi.org/10.1038/ni1539DOI Listing
December 2007

Development, cytokine profile and function of human interleukin 17-producing helper T cells.

Nat Immunol 2007 Sep 5;8(9):950-7. Epub 2007 Aug 5.

Department of Discovery Research, Schering-Plough Biopharma (formerly DNAX Research), Palo Alto, California 94304-1104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni1497DOI Listing
September 2007

T cells doing it for themselves: TGF-beta regulation of Th1 and Th17 cells.

Immunity 2007 May;26(5):547-9

Schering-Plough Biopharma, 901 California Avenue, Palo Alto, California 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2007.05.003DOI Listing
May 2007

Essential roles of IL-12 and dendritic cells but not IL-23 and macrophages in lupus-like diseases initiated by cell surface HSP gp96.

Eur J Immunol 2007 Mar;37(3):706-15

Center for Immunotherapy of Cancer and Infectious Diseases, Department of Immunology, University of Connecticut School of Medicine, Farmington, CT 06030-1601, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/eji.200636643
Publisher Site
http://dx.doi.org/10.1002/eji.200636643DOI Listing
March 2007

Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation.

Annu Rev Immunol 2007 ;25:221-42

Discovery Research, Schering-Plough Biopharma, Palo Alto, California 94304-1104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev.immunol.22.012703.104758DOI Listing
June 2007

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.

J Exp Med 2006 Nov 6;203(12):2673-82. Epub 2006 Nov 6.

Department of Cell Signaling, Graduate School, and COE Program for Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone, Tokyo Medical and Dental University, Tokyo 113-8549, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20061775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118166PMC
November 2006

Interleukin-23 drives innate and T cell-mediated intestinal inflammation.

J Exp Med 2006 Oct 9;203(11):2473-83. Epub 2006 Oct 9.

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, England, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20061099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118132PMC
October 2006

IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

J Exp Med 2006 Oct 9;203(11):2485-94. Epub 2006 Oct 9.

Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20061082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118119PMC
October 2006

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Cell 2006 Sep;126(6):1121-33

Molecular Pathogenesis Program, Skirball Institute of Biomolecular Medicine, New York University School of Medicine, 540 First Avenue, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2006.07.035DOI Listing
September 2006

TGF-beta, a 'double agent' in the immune pathology war.

Nat Immunol 2006 Jun;7(6):557-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni0606-557DOI Listing
June 2006

Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy.

Curr Opin Infect Dis 2006 Jun;19(3):245-52

Discovery Research, Schering-Plough Biopharma, Palo Alto, California 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.qco.0000224818.42729.67DOI Listing
June 2006

Understanding the IL-23-IL-17 immune pathway.

Trends Immunol 2006 Jan 14;27(1):17-23. Epub 2005 Nov 14.

Discovery Research, DNAX Research Inc., 901 California Ave, Palo Alto, CA 94304-1104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.it.2005.10.003DOI Listing
January 2006

IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12.

J Immunol 2004 Aug;173(3):1887-93

Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.173.3.1887DOI Listing
August 2004

NK cells regulate CD4 responses prior to antigen encounter.

J Immunol 2003 Jul;171(1):234-9

Department of Neurology, University of Southern California, Keck School of Medicine, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.171.1.234DOI Listing
July 2003

The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).

Cytokine Growth Factor Rev 2002 Aug-Oct;13(4-5):403-12

Department of Experimental Pathology, DNAX Research Inc., 901 California Avenue, Palo Alto, CA 94304-1104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1359-6101(02)00025-4DOI Listing
March 2003